We extend our heartfelt thanks to everyone who supported our vision for a world where HIV ... first-line or second-line drugs. Because they work differently to existing drugs, they remain active ...

Improved drug ... antiretroviral medicines, termed nanoART, across the BBB and affect the biodistribution and clinical benefit for HIV-1 disease. The review is divided into four major parts. The ...

A new study reports that the type 2 diabetes drug metformin could help people living with HIV who are using antiretroviral drugs. In a previous study, after three months of using metformin ...

Efavirenz is an important drug for treating HIV infection, but it has negative effects that can ... used a novel combination approach to increase understanding of the relevant mechanisms. First, ...

Metformin, a drug used to treat type 2 diabetes, could help deplete the viral reservoir and eliminate it entirely in people ...

Patients with HIV treated with antiretroviral therapy (ART) have a 31.5% chance of being anemic with many significantly ...

Efavirenz is an important drug for treating HIV infection, but it has negative effects that can significantly impact patients ...

Clinical trials for the injectable HIV prevention drug lenacapavir have yielded significant results, with the drug proving 89% more effective than daily oral pre-exposure prophylaxis among gay ...

All of that changed after January when he switched to taking the antiretroviral drug dolutegravir to ... dolutegravir a preferred first-line treatment for HIV, given its limited side effects ...

“Since 1953, when the five-day trading week in its current form began, this year ranks as the worst first week for the S&P 500 on record,” Bespoke, a wealth-management and research ...

The US-based Gilead Sciences’ long-acting injectable HIV drug lenacapavir is at the centre of a patent opposition case scheduled to come up this week at the Indian Patent Office (IPO).